INTT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INTT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
inTest's change in receivables for the quarter that ended in Dec. 2023 was $2.5 Mil. It means inTest's Accounts Receivable declined by $2.5 Mil from Sep. 2023 to Dec. 2023 .
inTest's change in receivables for the fiscal year that ended in Dec. 2023 was $3.0 Mil. It means inTest's Accounts Receivable declined by $3.0 Mil from Dec. 2022 to Dec. 2023 .
inTest's Accounts Receivable for the quarter that ended in Dec. 2023 was $18.2 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. inTest's Days Sales Outstanding for the three months ended in Dec. 2023 was 63.39.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. inTest's liquidation value for the three months ended in Dec. 2023 was $30.4 Mil.
The historical data trend for inTest's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
inTest Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | 1.24 | 0.89 | -4.78 | -4.89 | 2.99 |
inTest Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Change In Receivables | Get a 7-Day Free Trial | 0.01 | 0.29 | -0.66 | 0.85 | 2.51 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
inTest (AMEX:INTT) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
inTest's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 18.175 | / | 26.162 | * | 91 |
= | 63.39 |
2. In Ben Graham's calculation of liquidation value, inTest's accounts receivable are only considered to be worth 75% of book value:
inTest's liquidation value for the quarter that ended in Dec. 2023 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 45.26 | - | 38.548 | + | 0.75 * 18.175 | + | 0.5 * 20.089 |
= | 30.4 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of inTest's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Dews Joseph W Iv | director | C/O INTEST CORP, 804 EAST GATE DR., SUITE 200, MT. LAUREL NJ 08054 |
Scott Eric Nolen | officer: Division Pres-Process Tech | C/O INTEST CORP, 804 EAST GATE DRIVE, MT LAUREL NJ 08054 |
Michael Tanniru | officer: Div. President, Envir. Tech. | C/O INTEST CORP, 804 EAST GATE DR, SUITE 200, MT. LAUREL NJ 08054 |
Grant Richard N. Jr. | director, officer: President & CEO | C/O INTEST CORP, 804 EAST GATE DR, SUITE 200, MT. LAUREL NJ 08054 |
Gregory Martel | officer: VP&GM-Environmental Tech | C/O INTEST CORP, 804 EAST GATE DRIVE, MT LAUREL NJ 08054 |
Mcmanus Joseph Richard Jr. | officer: Division Pres-Electronic Test | C/O INTEST CORP, 804 EAST GATE DRIVE, MT LAUREL NJ 08054 |
Duncan Gilmour | officer: CFO, Treasurer & Secretary | 804 EAST GATE DRIVE, SUITE 200, MT. LAUREL NJ 08054 |
Gerald J. Maginnis | director | 280 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10023 |
James Pelrin | officer: GM-Temp Mgmt Product Segment | C/O INTEST CORP, 804 EAST GATE DRIVE, SUITE 200, MT. LAUREL NJ 08054 |
Jeffrey A Beck | director | C/O INTEST CORP, 804 EAST GATE DR., SUITE 200, MT. LAUREL NJ 08054 |
William Kraut | director | C/O INTEST CORP, 804 EAST GATE DR., SUITE 200, MT. LAUREL NJ 08054 |
Robert E Matthiessen | director, officer: President and CEO | C/O INTEST CORP, 804 EAST GATE DRIVE, SUITE 200, MT. LAUREL NJ 08054 |
Nokomis Capital, L.l.c. | 10 percent owner | 1717 MCKINNEY AVENUE, SUITE 850, DALLAS TX 75202 |
Satterfield Thomas A Jr | 10 percent owner | 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243 |
Kristen Holt Thompson | other: Member of 10% 13d Group | C/O INTEST CORP, 804 EAST GATE DR., SUITE 200, MT. LAUREL NJ 08054 |
From GuruFocus
By Marketwired Marketwired • 08-16-2018
By gurufocus 10qk • 08-13-2010
By PRNewswire PRNewswire • 05-30-2023
By GF Value GF Value • 06-10-2021
By Sydnee Gatewood • 04-21-2023
By gurufocus • 07-18-2009
By gurufocus 10qk • 11-13-2009
By GuruFocus Research • 11-03-2023
By GF Value GF Value • 05-07-2021
By GF Value GF Value • 04-05-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.